Abstract
While cardiac ventricle assist devices (VAD) as bridges to transplant (BTT) and destination therapies (DT) are advancing technical, medical and surgical supports for end stage heart disease collateral ethical advances have not occurred. The increasing use of elective or emergent VADs are creating unique ethical issues. This is a 12 point patient protocol to reduce potential ethical dilemmas.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Paper Title
Journal
Date
